Millennium Management
FRTX

Millennium Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Millennium Management’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-32
Closed -$125K – 3870
2013
Q3 		$125K Buy
32
+25
+357% +$188K ﹤0.01% 3176
2013
Q2 		$71K Buy
+7
New +$77.5K ﹤0.01% 2894

Other funds holding FRTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Millennium Management's FRTX Position: Q2 2023 in Review

Millennium Management sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q2 2023, closing a stake of 20,912 shares — an estimated $14K sold.

Millennium Management first reported a position in FRTX in Q2 2013 and held it in 17 quarters. The position peaked at $256K in Q4 2017. 15 funds tracked by Wall St. Rank hold FRTX as of Q2 2023.

  • Millennium Management reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Millennium Management sold 20,912 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $14K.
  • Millennium Management first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and held it in 17 quarters.
  • Millennium Management's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $256K in Q4 2017.
  • 15 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.